These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma. Andrews JS; Berger AE; Ware CF J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453 [TBL] [Abstract][Full Text] [Related]
4. Cloning, expression and cross-linking analysis of the murine p55 tumor necrosis factor receptor. Barrett K; Taylor-Fishwick DA; Cope AP; Kissonerghis AM; Gray PW; Feldmann M; Foxwell BM Eur J Immunol; 1991 Jul; 21(7):1649-56. PubMed ID: 1647956 [TBL] [Abstract][Full Text] [Related]
5. Cell density-dependent regulation of cell surface expression of two types of human tumor necrosis factor receptors and its effect on cellular response. Pocsik E; Mihalik R; Ali-Osman F; Aggarwal BB J Cell Biochem; 1994 Apr; 54(4):453-64. PubMed ID: 8014194 [TBL] [Abstract][Full Text] [Related]
6. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. Lantz M; Gullberg U; Nilsson E; Olsson I J Clin Invest; 1990 Nov; 86(5):1396-1402. PubMed ID: 2173717 [TBL] [Abstract][Full Text] [Related]
7. Variation in serum levels of the soluble TNF receptors among healthy individuals. Aderka D; Engelmann H; Shemer-Avni Y; Hornik V; Galil A; Sarov B; Wallach D Lymphokine Cytokine Res; 1992 Jun; 11(3):157-9. PubMed ID: 1327192 [TBL] [Abstract][Full Text] [Related]
8. Two crystal forms of the extracellular domain of type I tumor necrosis factor receptor. Rodseth LE; Brandhuber B; Devine TQ; Eck MJ; Hale K; Naismith JH; Sprang SR J Mol Biol; 1994 Jun; 239(2):332-5. PubMed ID: 8196061 [TBL] [Abstract][Full Text] [Related]
9. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins. Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor: receptors and inhibitors. Loetscher H; Steinmetz M; Lesslauer W Cancer Cells; 1991 Jun; 3(6):221-6. PubMed ID: 1654969 [TBL] [Abstract][Full Text] [Related]
11. Involvement of an Asn/Val cleavage site in the production of a soluble form of a human tumor necrosis factor (TNF) receptor. Site-directed mutagenesis of a putative cleavage site in the p55 TNF receptor chain. Gullberg U; Lantz M; Lindvall L; Olsson I; Himmler A Eur J Cell Biol; 1992 Aug; 58(2):307-12. PubMed ID: 1330568 [TBL] [Abstract][Full Text] [Related]
12. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Aderka D; Englemann H; Hornik V; Skornick Y; Levo Y; Wallach D; Kushtai G Cancer Res; 1991 Oct; 51(20):5602-7. PubMed ID: 1655258 [TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors. Kost ER; Mutch DG; Herzog TJ Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of tumor necrosis factor receptors 1 and 2 of the goldfish (Carassius aurutus L.). Grayfer L; Belosevic M Mol Immunol; 2009 Jul; 46(11-12):2190-9. PubMed ID: 19446337 [TBL] [Abstract][Full Text] [Related]
15. Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors. Pocsik E; Mihalik R; Penzes M; Loetscher H; Gallati H; Aggarwal BB J Cell Biochem; 1995 Nov; 59(3):303-16. PubMed ID: 8567749 [TBL] [Abstract][Full Text] [Related]
16. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines. Browning J; Ribolini A J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545 [TBL] [Abstract][Full Text] [Related]
17. Human TNF mutants with selective activity on the p55 receptor. Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906 [TBL] [Abstract][Full Text] [Related]
18. Increased levels of soluble tumor necrosis factor-alpha receptors in serum from pregnant women and in serum and urine samples from newborns. Austgulen R; Liabakk NB; Lien E; Espevik T Pediatr Res; 1993 Jan; 33(1):82-7. PubMed ID: 8381953 [TBL] [Abstract][Full Text] [Related]
19. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures. Williams LM; Gibbons DL; Gearing A; Maini RN; Feldmann M; Brennan FM J Clin Invest; 1996 Jun; 97(12):2833-41. PubMed ID: 8675695 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system. Warzocha K; Bienvenu J; Coiffier B; Salles G Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]